scholarly article | Q13442814 |
P2093 | author name string | Wolfram Dempke | |
Roland Zippel | |||
P2860 | cites work | Biochimica et Biophysica Acta | Q864239 |
Cloning of FRK, a novel human intracellular SRC-like tyrosine kinase-encoding gene | Q24305125 | ||
Rak, a novel nuclear tyrosine kinase expressed in epithelial cells | Q24311867 | ||
The role of Src in solid tumors | Q24616659 | ||
Tyrosine kinase signalling in breast cancer: epidermal growth factor receptor and c-Src interactions in breast cancer | Q24803054 | ||
Proceedings of the American Association for Cancer Research | Q27717904 | ||
The hunting of the Src | Q28199081 | ||
Focal adhesion kinase enhances signaling through the Shc/extracellular signal-regulated kinase pathway in anaplastic astrocytoma tumor biopsy samples | Q28216057 | ||
Lack of mutation at codon 531 of SRC in advanced colorectal cancers from Italian patients | Q28346761 | ||
Modular binding domains in signal transduction proteins | Q29617351 | ||
Regulation, substrates and functions of src | Q30014830 | ||
c-Src and cooperating partners in human cancer | Q30434520 | ||
Src family kinases, key regulators of signal transduction | Q30434839 | ||
Tyr527 is phosphorylated in pp60c-src: implications for regulation | Q34383180 | ||
A protein tyrosine kinase involved in regulation of pp60c-src function | Q34419128 | ||
Activating SRC mutation in a subset of advanced human colon cancers | Q34492512 | ||
Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60c-src | Q34580219 | ||
A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: a California Cancer Consortium study | Q35576853 | ||
The role of Src in prostate cancer | Q36787631 | ||
Management of imatinib-resistant CML patients | Q36997019 | ||
Dasatinib in chronic myeloid leukemia: a review. | Q37523302 | ||
Phase 1 pharmacokinetic and drug-interaction study of dasatinib in patients with advanced solid tumors | Q43182188 | ||
Epidermal growth factor receptor (EGFR) ubiquitination as a mechanism of acquired resistance escaping treatment by the anti-EGFR monoclonal antibody cetuximab | Q81098062 | ||
P433 | issue | 10 | |
P407 | language of work or name | German | Q188 |
P304 | page(s) | 711-715 | |
P577 | publication date | 2010-10-28 | |
P1433 | published in | Medizinische Klinik | Q11776847 |
P1476 | title | SRC kinases in tumor therapy | |
P478 | volume | 105 |
Search more.